Individual Investigator Award

2007 Grant Recipients

• Qin Yang, MD, PhD, University of Washington
  BRCA/AKT1 Pathway in Ovarian Cancer
• Tian-Li Wang, PhD, Johns Hopkins University School of Medicine
  How One Biological Pathway Running Amok in Ovarian Cells Contributes to Cancer
• John Risinger, PhD, Michigan State University
  Understanding the Genetics of Metastasis May Help Prevent and Stop It
• David MacLaughlin, PhD, Massachusetts General Hospital
  Validation of a Human Ovarian Cancer Stem Cell Signature and its Use to Select Optimal Therapeutic Strategies for Ovarian Cancer Patients
• Mitchell Ho, PhD , National Cancer Institute
  A New Treatment that Aims to Stop Metastasis

2005 Grant Recipients

• Min Zhu, PhD, UCLA School of Medicine
  A Protein’s Possible Role in Ovarian Cancer Metastasis
• Xiaochun Yu, MD, PhD, University of Michigan
  How Hereditary and Non-Hereditary Cancer May Have Something in Common
• Terry A. Van Dyke, PhD, University of North Carolina - Chapel Hill
  Developing a Mouse Model of Ovarian Cancer
• Jill K. Slack-Davis, PhD, University of Virginia - Charlottesville
  How Ovarian Cancer Cells Might Metastasize
• Manish S. Patankar, PhD, University of Wisconsin-Madison Medical School
  A Possible Explanation for How Ovarian Cells Evade Immune Response
• Lawrence Kane, PhD, University of Pittsburgh
  Characterizing Molecular Defects in Ovarian Cancer
• Xiaolong He, PhD, University of Chicago
  One Cause of Ovarian Cancer May Lay in Problems with mRNA
• Laurent Brard, MD, PhD, Brown University
  Removing Iron from Ovarian Cancer Cells May Stop Their Growth

2004 Grant Recipients

• Anda Vlad, MD, PhD, University of Pittsburgh
  Immunotherapy of Ovarian Cancer Using Certain Tumor Specific Glycopeptides
• Chris Taylor, PhD, Georgetown University
  DNA Vaccines in Ovarian Cancer
• Elizabeth Swisher, MD, University of Washington
  Understanding the Role of Tumor Blood Vessel Growth and Circulating Tumor DNA in Women with Ovarian Cancer
• Richard Pietras, MD, PhD, UCLA School of Medicine
  Developing Drugs to Block Blood Vessel Growth in Ovarian Tumors
• Wael El Shamy, PhD, Dana Farber Cancer Institute
  Another Protein Made by BRCA1 and its Role in Ovarian Cancer
• Shu-Wing Ng, PhD, Brigham and Women’s Hospital
  Studying Membrane Proteins for Early Diagnosis and Disease Progression in Ovarian Cancer

2003 Grant Recipients

• Changping Zou, MD, PhD, University of Arizona
  Finding Biomarkers for Early Detection of Ovarian Cancer
• Karen M. Vasquez, PhD, MD Anderson Cancer Center
  Trying to Understand the Mechanism for Cisplatin
• Parameshwar Mahareshti, DVM, University of Alabama - Birmingham
  A New Combination Drug Treatment for Ovarian Cancer
• Robert Lucito, PhD, Cold Spring Harbor Laboratory
  Gene Copy Number Alterations in Ovarian Cancer
• Thomas Franke, MD, PhD, Columbia University Medical Center
  Finding Molecules to Stop an Abnormal Signaling Pathway in Ovarian Cancer
• Ronny I. Drapkin, MD, PhD, Dana Farber Cancer Institute
  Ovarian Cancer Biomarkers: Identification, Validation and Assessment of Biological Function

2002 Grant Recipients

• Honami Naora, MD, PhD, MD Anderson Cancer Center
  How Cells Migrate in the Drosophila Ovary May Lead to a Better Understanding of Ovarian Cancer Metastasis
• Robert Hickey, PhD, Indiana University School of Medicine
  Mechanisms of Gene Instability in Ovarian Cancer
• Andrew K. Godwin, PhD, Fox Chase Cancer Center
  Identification of Novel Genetic Markers of Response to Imatinib Mesylate in Ovarian Carcinomas
• Xiang-Jun Fang, PhD, MD Anderson Cancer Center
  The Role of a Lipid Molecule in Promoting Ovarian Cancer Tumor Growth
• Fergus Couch, PhD, Mayo Clinic
  Finding Genes Associated with Drug Resistance in Ovarian Cancer
• Penny Clarke, PhD, University of Colorado - Boulder
  Sensitization of Human Ovarian Cells to a Protein that Causes Cell Death

2001 Grant Recipients

• Jingwei Yu, PhD, Eleanor Roosevelt Institute
  Development of DNA Methylation Based Ovarian Cancer Specific Molecular Markers
• Bin Ye, PhD, Brigham and Women’s Hospital, Dana Farber Cancer Institute
  Finding Serum and Urine Protein/Peptide Markers of Ovarian Cancer for Screening
• Elizabeth Ann Poynor, MD, Memorial Sloan Kettering Cancer Center
  The Role of a Novel Gene, ZIC 2, in Causing Sporadic Ovarian Cancer
• Steven W. Johnson, PhD, University of Pennsylvania
  Characterizing Differential Gene Expression of Drug Sensitive and Resistant Ovarian Cancer
• Paul Cairns, PhD, Fox Chase Cancer Center
  Novel Approaches for Early Diagnosis of Ovarian Cancer

2000 Grant Recipients

• Gary Yiu, PhD, Brigham and Women’s Hospital, Dana Farber Cancer Institute
  Molecular Classification of Epithelial Ovarian Tumors
• Xiang-Xi Xu, PhD, Fox Chase Cancer Center
  Studying the Role of a Novel Protein, Dab2, in Ovarian Cancer
• Iman Osman, MD, University of New Mexico
  Hypoxia Inducible Factor-1 alpha (HIF-1): A Potential New Prognostic Marker for Advanced Ovarian Cancer and Target of Treatment
• William Irvin, MD, University of Virginia Medical Center
  Vaccine Trial for Ovarian Cancer
• Wei Hu, MD, PhD, MD Anderson Cancer Center
  Effects of a Novel Combination Drug Treatment on Cell Lines Derived from Human Ovarian Cancer

1999 Grant Recipients

• Jon Wiener, PhD, MD Anderson Cancer Center
  Studying the Role of the Protein Src in Ovarian Cancer
• Farr Nezhat, MD, Mount Sinai School of Medicine
  Comparative Immunohistochemical and in Situ DNA Hybridization Studies of Endometriosis and Ovarian Cancer
• Dineo Khabele, MD, Albert Einstein College of Medicine/Montefiore Medical Center
  Patterns of Gene Expression in Ovarian Cancer
• Abbie Fields, MD, Albert Einstein College of Medicine/Montefiore Medical Center
  Comparing Hereditary Cancer of the Peritoneum to Hereditary Ovarian Cancer
• Setsuko Chambers, MD, Yale University
  Androgens and the Emergence of the Ovarian Cancer Phenotype

1998 Grant Recipients

• Yosef Yarden, PhD, The Weizmann Institute of Science
  The ErbB Signaling Network-Potential Targets for Prognosis and Therapy of Ovarian Cancer
• Timothy Lane, PhD, UCLA School of Medicine
  Tumor Gene Overexpression: A Functional Assay to Identify New Tumor Suppressor Genes
• Barry Kacinski, MD, PhD, Yale University
  Steroid Hormone Regulation of the Expression of Genes
• Ilana Cass, MD, Albert Einstein College of Medicine/Montefiore Medical Center
  Comparing Peritoneal and Ovarian Cancer
• Molly Brewer, DVM, MD, MS, MD Anderson Cancer Center
  How Might Chemopreventive Agents Against Ovarian Cancer Work